{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:19:48Z","timestamp":1780586388016,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.clinthera.2020.09.010","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T07:59:10Z","timestamp":1601971150000},"page":"e250-e258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pyridoxine and Magnesium Administration\u2013Induced Hyperactivity in Two Children With Autism Spectrum Disorder: Case Reports From a Clinical Trial"],"prefix":"10.1016","volume":"42","author":[{"given":"Abraham","family":"Debi Ann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narasimhan","family":"Udayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Senta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhasaparur Ganesan","family":"Rajanandh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2020.09.010_bib1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/aur.1836","article-title":"Social motivation and implicit theory of mind in children with autism spectrum disorder","volume":"10","author":"Burnside","year":"2017","journal-title":"Autism Res"},{"key":"10.1016\/j.clinthera.2020.09.010_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10803-017-3279-x","article-title":"School age outcomes of children diagnosed early and later with autism spectrum disorder","volume":"48","author":"Clark","year":"2018","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.clinthera.2020.09.010_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/09540261.2018.1458706","article-title":"An update on pharmacotherapy of autism spectrum disorder in children and adolescents","volume":"30","author":"Goel","year":"2018","journal-title":"Int Rev Psychiatr"},{"key":"10.1016\/j.clinthera.2020.09.010_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/aur.239","article-title":"Global prevalence of autism and other pervasive developmental disorders","volume":"5","author":"Elsabbagh","year":"2012","journal-title":"Autism Res"},{"key":"10.1016\/j.clinthera.2020.09.010_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/DBP.0000000000000136","article-title":"Parent health beliefs, social determinants of health, and child health services utilization among U.S. school-age children with autism","volume":"36","author":"Zuckerman","year":"2015","journal-title":"J\u00a0Dev Behav Pediatr"},{"key":"10.1016\/j.clinthera.2020.09.010_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.explore.2013.10.005","article-title":"Intention-based therapy for autism spectrum disorder: promising results of a wait-list control study in children","volume":"10","author":"Weiner","year":"2014","journal-title":"Explore"},{"key":"10.1016\/j.clinthera.2020.09.010_bib7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1176\/ajp.135.4.472","article-title":"The effect of high doses of vitamin B6 on autistic children: a double-blind crossover study","volume":"135","author":"Rimland","year":"1978","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.clinthera.2020.09.010_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01531686","article-title":"Effects of pyridoxine and magnesium on autistic symptoms\u2014initial observations","volume":"11","author":"Lelord","year":"1981","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.clinthera.2020.09.010_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF02212198","article-title":"Brief report: an open middle-term study of combined vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment","volume":"18","author":"Martineau","year":"1988","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.clinthera.2020.09.010_bib10","first-page":"53","article-title":"Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism","volume":"19","author":"Mousain-Bosc","year":"2006","journal-title":"Magnes Res"},{"key":"10.1016\/j.clinthera.2020.09.010_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0006-3223(85)90019-8","article-title":"Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism","volume":"20","author":"Martineau","year":"1985","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.clinthera.2020.09.010_bib12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0006-3223(86)90192-7","article-title":"Long term effects of combined vitamin B6-magnesium administration in an autistic child","volume":"21","author":"Martineau","year":"1986","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.clinthera.2020.09.010_bib13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1469-8749.1989.tb04067.x","article-title":"Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behaviour","volume":"31","author":"Martineau","year":"1989","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.clinthera.2020.09.010_bib14","first-page":"284","article-title":"Pyridoxine treatment in a subgroup of children with pervasive developmental disorders","volume":"44","author":"Kuriyama","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.clinthera.2020.09.010_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM198308253090801","article-title":"Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome","volume":"309","author":"Schaumburg","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clinthera.2020.09.010_bib16","unstructured":"Vitamin B6 Fact Sheet for Health Professionals Retrived on 31\/08\/2020 from https:\/\/ods.od.nih.gov\/factsheets\/VitaminB6-HealthProfessional"},{"key":"10.1016\/j.clinthera.2020.09.010_bib17","first-page":"437","article-title":"The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children","volume":"55","author":"Bhagavan","year":"1975","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2020.09.010_bib18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/jnnp.36.4.696","article-title":"Role of vitamin B6 in neurobiology: advances in biochemical psychopharmacology","volume":"36","author":"Webster","year":"1973","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.clinthera.2020.09.010_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01066428","article-title":"Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium","volume":"23","author":"Tolbert","year":"1993","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.clinthera.2020.09.010_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1025861522935","article-title":"High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study","volume":"27","author":"Findling","year":"1997","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.clinthera.2020.09.010_bib21","first-page":"CD003497","article-title":"Combined vitamin B6-magnesium treatment in autism spectrum disorder","volume":"4","author":"Nye","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2020.09.010_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/BTER:109:2:097","article-title":"Magnesium profile in autism","volume":"109","author":"Strambi","year":"2006","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.clinthera.2020.09.010_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/acm.2006.12.59","article-title":"Abnormally high plasma levels of vitamin B6 in children with autism not taking supplements compared to controls not taking supplements","volume":"12","author":"Adams","year":"2006","journal-title":"J\u00a0Altern Complement Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820304604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820304604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:52:51Z","timestamp":1758963171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291820304604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0149291820304604"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.09.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyridoxine and Magnesium Administration\u2013Induced Hyperactivity in Two Children With Autism Spectrum Disorder: Case Reports From a Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}